Sola Charles🇳🇬 (@solazed) header
Sola Charles🇳🇬 (@solazed) profile picture

NMMA Most Innovative Reporter of the year/Public Health Reporter of the year | HIV/AIDS+SRHR advocate | Health Editor Vanguard Newspaper | Great father &husband

Vancouver, British Columbia
Joined December 2008
Photo by Sola Charles🇳🇬 (@solazed)Photo by Sola Charles🇳🇬 (@solazed)Photo by Sola Charles🇳🇬 (@solazed)Photo by Sola Charles🇳🇬 (@solazed)Photo by Sola Charles🇳🇬 (@solazed)Photo by Sola Charles🇳🇬 (@solazed)Photo by Sola Charles🇳🇬 (@solazed)Photo by Sola Charles🇳🇬 (@solazed)Photo by Sola Charles🇳🇬 (@solazed)Photo by Sola Charles🇳🇬 (@solazed)
Japanese researchers have successfully removed extra copy of chromosome 21 from human cells associated with #Downsyndrome raising possibility of a new approach to tackling #trisomy21 The researchers used CRISPR-Cas9 gene-editing technology healthnewsextra.blogspot.com… – at Igbologun, Nigeria
222
Sola Charles🇳🇬 retweeted
A positive milestone in #Nigeria’s #Ebola response: all 62 identified contacts of the case reported on 20 October have completed 21 days of monitoring, with no secondary transmission detected. As the second half of the 42-day countdown begins, @WHO maintains its support and heightened vigilance. My congratulations to the government, health workers and responders for their success in preventing the spread of the Bundibugyo virus.
14
232
17
462
39,198
Sola Charles🇳🇬 retweeted
BREAKING: The Pan American Health Organization, an international health body, has revoked the U.S.’s measles elimination status, WSJ reports.
28
360
65
943
43,441
Sola Charles🇳🇬 retweeted
🚨 A Tiny Dose of Bee Venom Showed a Powerful Effect Against Aggressive Breast Cancer Cells Scientists in Australia discovered something remarkable while studying honeybee venom. The secret ingredient is melittin, a natural compound found in bee venom. In laboratory experiments, it damaged the outer membranes of aggressive breast cancer cells, including triple-negative and HER2-enriched cancer cells, within just 60 minutes. But that wasn't all. Within 20 minutes, melittin also disrupted chemical signals that help cancer cells grow and multiply. Researchers even found that melittin could enhance the effects of a chemotherapy drug in animal experiments. Could this tiny molecule inspire a new approach to fighting breast cancer? The research is promising, but human trials are needed to establish whether it can become a safe and effective treatment. Bee venom is NOT a proven cancer cure. Source:
Duffy, C., et al. (2020). Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. npj Precision Oncology, 4, 24.
6
43
158
3,223
Sola Charles🇳🇬 retweeted
Research shows children who get outside regularly are more mentally stable. Researchers at the University of Exeter used data from Children of the 90s, a long-running study in England that has followed the same families for decades. They looked at how often 4,219 children were taken to parks or playgrounds from birth to age 11 and compared that with assessments of their mental health and social-emotional development between ages 4 and 11. Children who visited a park at least once a week scored on average 16.5% better than those who went less often. Kids also did better during the stretches of childhood when they were visiting parks more, even after the researchers accounted for family income and hardship. The study was published in the Journal of Epidemiology and Community Health. Parks give children room to run, play and mix with other kids, all of which support mental and physical health. "We believe parks could be more than places to play, but an important resource for children's healthy development," says lead researcher Mark Ferguson. And unlike most things that help kids thrive, a trip to the park is free. That said, the study shows a link rather than proof that park trips caused the better scores, and it comes from one region of the UK, so the team wants to see whether it holds in more diverse communities. On top of that, the benefits depend on parks being safe, welcoming and easy to reach. But it adds real weight to the case for treating good local parks as part of children's health, not just a nice extra. source: Ferguson, M., et al. (2026). Park visits and social-emotional development throughout childhood: A longitudinal analysis of ALSPAC. Journal of Epidemiology and Community Health.
1
32
3
97
4,215
Sola Charles🇳🇬 retweeted
🌍 HIV/AIDS: TOP 30 COUNTRIES WITH THE MOST PEOPLE LIVING WITH HIV (1990–2026) The HIV epidemic remains one of the world's major public health challenges. This data visualization shows how the number of people living with HIV has changed across 30 countries over more than three decades. 🖇️ Source: IHME — Global Burden of Disease (GBD) 2023 📈 Indicator: Number of people living with HIV (all ages, both sexes). ⚠️ Historical data covers 1990–2023. Figures for 2024–2026 are trend-adjusted estimates, not official IHME observations.
247
441
89
1,927
1,264,556
Interesting discovery...
What if light and sound could help the brain fight Alzheimer’s disease? Scientists are studying an unusual approach that uses light and sound pulsing 40 times per second to stimulate gamma brain waves. Early research suggests this stimulation may activate the brain’s immune cells, helping them clear harmful protein buildup linked to Alzheimer’s. Human trials have also shown promising results, including potential benefits for brain health and memory. However, this remains an experimental approach, and larger studies are needed to confirm its effectiveness. A simple rhythm could hold an exciting clue to fighting one of the world's most challenging brain diseases.
12
Sola Charles🇳🇬 retweeted
What if light and sound could help the brain fight Alzheimer’s disease? Scientists are studying an unusual approach that uses light and sound pulsing 40 times per second to stimulate gamma brain waves. Early research suggests this stimulation may activate the brain’s immune cells, helping them clear harmful protein buildup linked to Alzheimer’s. Human trials have also shown promising results, including potential benefits for brain health and memory. However, this remains an experimental approach, and larger studies are needed to confirm its effectiveness. A simple rhythm could hold an exciting clue to fighting one of the world's most challenging brain diseases.
6
34
2
83
2,254
Heteropaternal superfecundation vanguardngr.com/2017/01/twin…
TWO TWINS, TWO DIFFERENT FATHERS: A DNA TEST REVEALED AN EXTRAORDINARY SECRET! In September 2022, a 19-year-old woman in Brazil gave birth to twin boys. When their biological father was questioned, DNA tests revealed a remarkable surprise: each twin had a different biological father! How could this happen? The answer lies in an extremely rare biological phenomenon called heteropaternal superfecundation. Sometimes, a woman releases two eggs during the same menstrual cycle. If sperm from two different men fertilize those eggs, both babies can develop together as twins, even though they have different fathers. In this Brazilian case, the mother reportedly had sexual encounters with two men during the same fertile period, making this extraordinary event possible. The boys were fraternal twins, sharing the same mother but having different biological fathers. Have you ever heard of twins having two different biological fathers? Source: Folha de S.Paulo. (2022, September 8). Jovem tem gêmeos de pais diferentes
15
Time to #StopTB in its tracks! Elimination as a public health problem is an achievable intermediate goal through the WHO #EndTBStrategy framework for dramatically reducing TB incidence and deaths through prevention, diagnosis, treatment and stronger health systems
Progress is being made in tackling tuberculosis (TB). But it's far too slow. The TB incidence rate has fallen by just 14% since 2015, far short of the 50% reduction milestone for 2025. TB deaths have fallen by 35% over the same period, reaching the first mortality milestone in the End TB Strategy, five years late. Ending TB is possible – with political will, domestic investment, and research to drive progress. 🔗 bit.ly/48P8Auh
1
1
17
Sola Charles🇳🇬 retweeted
A new experimental drug turns prostate cancer's own proteins against it, shrinking tumours in preclinical tests. Instead of blocking or destroying the proteins that fuel cancer growth, scientists at the University of Michigan have created a molecule that physically rewires how they connect inside the cell. Published in the journal Nature, this breakthrough introduces a bold new class of medicine called Domain-Alteration Chimeras, or DALTACs. Prostate cancer relies on a master protein called the androgen receptor, which teams up with a helper protein known as p300 to switch on tumour-driving genes. Aggressive tumours eventually outsmart standard drugs that block this receptor, and destroying an essential helper protein like p300 across the entire body causes severe collateral damage to healthy organs. To bypass both problems, researchers designed a dual-headed molecule that acts like a wrench thrown between two moving gears. Rather than demolishing the proteins, the drug grabs both at once and locks them together in an awkward, unnatural position. This forced grip jams the cancer cell's genetic control centre, shutting down tumour growth on the spot. Because the drug needs the prostate cancer receptor to trap the helper protein, its attack stays strictly confined to tumour cells while sparing healthy tissue. Designed to be taken as a simple oral pill, this therapy triggered dramatic tumour shrinkage in laboratory models of treatment-resistant prostate cancer with zero noticeable toxicity. By turning a tumour's own survival machinery into a weapon against itself, this discovery opens a powerful new path for defeating treatment-resistant cancers. Study details: Luo, J., Yang, J., Tien, J. CY, et al. Domain-alteration chimeras rewire oncogenic complexes in prostate cancer. Nature (2026). DOI: 10.1038/s41586-026-11262-4
2
39
2
105
3,213
Sola Charles🇳🇬 retweeted
Nigeria's health sector has begun its 3rd Joint Annual Review (#JAR2026) under the theme "Together to Higher Ground", bringing together key stakeholders from government leadership, development partners, private sector innovators, civil society, and frontline health workers to assess progress in strengthening the health system, expanding access to quality healthcare, and protecting millions of people from the financial burden of illness. The JAR serves as a collaborative platform for stakeholders to analyse performance data down to the state and facility levels, enabling the health sector to learn from recent trends and strategically sustain operational gains. Through the Nigeria Health Sector Renewal Investment Initiative (NHSRII) and the Sector-Wide Approach (@SWApGov), several notable achievements were highlighted over the past three years: Over 3500 Primary Healthcare Centres revitalised, with 900 more underway. ₦249 billion disbursed to states through the Basic Healthcare Provision Fund between 2023 and Q3 2026, compared with ₦74 billion cumulatively over the preceding 10 years. · More than 100 million children vaccinated against measles and rubella. · More than 19 million adolescent girls vaccinated against HPV to prevent cervical cancer. · 24 million people covered by health insurance, up from 16 million. · Approximately 20,000 skilled birth attendants recruited across 22 states. · 10 world-class diagnostic centres completed and operational. · An 80% reduction in dialysis costs for more than 5,000 patients. @DrPavelUrsu noted: "Success will be measured in communities, through better services and progress towards universal health coverage and health security targets, and ultimately in healthier lives and lives saved" @muhammadpate highlighted that "national ownership and international cooperation work together when roles are clear and results reach our people." WHO, together with the UN, reaffirmed its commitment to supporting Nigeria's journey towards a stronger, more equitable, and resilient health system.
2
6
19
1,908
Keeping 14th September in the family...
Son - 14th September 2025 Mother - 14th September 1997 Grandfather - 14th September 1972 Great-grandmother - 14th September 1949 Great-great-grandfather - 14th September 1907 Yes, this American family really has five generation born on the same day! guinnessworldrecords.com/new…
41
Sola Charles🇳🇬 retweeted
Nigeria now has the most TikTok users in Africa with 61.4 million. Egypt comes in second place with 57.5 million. Source: Data Reportal's Digital Report.
36
62
6
532
51,720
Sola Charles🇳🇬 retweeted
Lagos, Nigeria 🇳🇬 -based Dazzle FC’s Under-12 team has won the 2026 Dana Cup in Hjørring, Denmark, triumphing over teams from 56 countries at one of the world’s largest youth football tournaments.
16
97
3
865
27,781
Sola Charles🇳🇬 retweeted
Nigerian-Born American Lawyer Shirley Emehelu Appointed New Jersey Lieutenant Governor, as She Makes History as the State’s First Immigrant to Hold Office
58
182
12
2,258
50,275
Sola Charles🇳🇬 retweeted
Experts just discovered that an FDA-approved pill jams the recycling system cancer cells depend on — and they die. The drug is eliglustat, sold as Cerdelga, which is approved in the U.S. for adults with Gaucher disease type 1, a rare inherited disorder. It blocks an enzyme called glucosylceramide synthase, and a team led by Can Senkal at VCU Massey Comprehensive Cancer Center tested what that does to cancer cells. When they treated several cancer cell lines with eliglustat, or switched the enzyme off genetically, the cells died. Looking closer, they found that the cells' lysosomes, the little sacs that break down worn-out parts so they can be reused, swelled up and stopped working, leaving undigested proteins, fats and old cell parts piling up inside. Fast-growing cancer cells lean heavily on that recycling, so losing it was fatal, and when the team used another compound to restart lysosome production, the cells survived. The study was published in Cell Death Discovery. For years, scientists assumed blocking this enzyme hurt cancer by letting a toxic fat called ceramide build up. This work shows the real damage comes from breaking the cell's recycling system, which changes how the drug might best be used. And because eliglustat has already been through safety testing and approval, it could reach cancer trials far faster than a brand-new compound. That said, all of this was done on cancer cells in dishes, not in animals or people, and the doses that kill cells in a lab may not be ones patients can safely take. The next step is testing whether the same lysosome breakdown happens in living tumors, which would decide if an old pill earns a new job. source: Straus, A. J., Kempelingaiah, S. K., Nguyen, S., Premanandh, S., et al., & Senkal, C. E. (2026). Targeting glucosylceramide generation induces cancer cell death through lysosomal dysfunction independent of ceramide accumulation. Cell Death Discovery.
8
58
4
242
9,189
T cells are the body's security and command system, they are part of the defence artillery that coordinate the immune response; there are Helper T cells, Killer T cells , Regulatory T cells and Memory T cells ... – at Igbologun, Nigeria
🧬 Your Body Has Special Cells That Stop It From Attacking Itself! What if the secret to fighting autoimmune diseases was already hidden inside our immune system? Scientists discovered a special group of cells called regulatory T cells (Tregs). Think of them as the body's peacekeepers. While other immune cells fight harmful invaders, Tregs help prevent the immune system from attacking healthy organs and tissues. This discovery, recognized with the 2025 Nobel Prize in Medicine, could open new doors for treating diseases such as type 1 diabetes, rheumatoid arthritis and multiple sclerosis. Instead of simply suppressing the immune system, researchers hope to develop treatments that teach it to restore its natural balance. Could these tiny cells hold the key to future autoimmune therapies? Source:
The Nobel Assembly at Karolinska Institutet. (2025, October 6). The Nobel Prize in Physiology or Medicine 2025.
1
33
Sola Charles🇳🇬 retweeted
The odds of meeting "the one" are just 1 in 562, a mathematician calculated. The number comes from British mathematician and TV presenter Rachel Riley, best known from the quiz show Countdown, who crunched the figures for the dating site eHarmony in 2017 With input from researchers at the University of Bath, the team weighed 18 factors that shape who we're actually interested in, such as preferred age, attractiveness, relationship status and how far from home we're willing to look. Once all of those filters were applied, only about 84,000 adults in the whole of the UK fit the average person's wish list, which works out to roughly a 1 in 562 chance of finding love. The odds weren't the same for everyone. Londoners did better at 1 in 394, simply because they're surrounded by more people, and the chances actually improved with age, from 1 in 1,024 for 18-to-24-year-olds to 1 in 304 for people aged 65 to 74. The calculation also suggested that small changes, like going to the gym, socializing with colleagues and their friends, looking a bit further from home, or trying online dating, all nudge the numbers in your favor. . source: Walker-Arnott, E. The odds of finding love in London today are... Time Out London.
10
13
4
78
3,991
The number of Nigerians covered by #healthinsurance increased from about 16m to nearly 24m in three years, the Federal Government has said, highlighting the expansion of financial protection as a major gain of its ongoing #healthsector reforms healthnewsextra.blogspot.com… – at Igbologun, Nigeria
1
1
21
From about 41 million people in 1955, Nigeria's population has climbed to an estimated 244.3 million, according to Worldometer, reflecting one of the most dramatic demographic expansions in the country's history healthnewsextra.blogspot.com… – at Igbologun, Nigeria
25